Patrick F. Smith - Jun 5, 2023 Form 4 Insider Report for Certara, Inc. (CERT)

Role
PRESIDENT, INTEGRATED DRUG DEV
Signature
/s/ Richard M. Traynor as attorney-in-fact for Patrick F. Smith
Stock symbol
CERT
Transactions as of
Jun 5, 2023
Transactions value $
-$411,691
Form type
4
Date filed
6/6/2023, 04:56 PM
Previous filing
Apr 3, 2023
Next filing
Oct 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERT Common Stock Sale -$412K -19.1K -24.16% $21.55 60K Jun 5, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2023.